Literature DB >> 26320870

A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.

Jianli Li1, Hongzheng Dai1, Yanming Feng1, Jia Tang1, Stella Chen1, Xia Tian1, Elizabeth Gorman1, Eric S Schmitt1, Terah A A Hansen2, Jing Wang3, Sharon E Plon4, Victor Wei Zhang5, Lee-Jun C Wong6.   

Abstract

Germline mutations in the DNA mismatch repair gene PMS2 underlie the cancer susceptibility syndrome, Lynch syndrome. However, accurate molecular testing of PMS2 is complicated by a large number of highly homologous sequences. To establish a comprehensive approach for mutation detection of PMS2, we have designed a strategy combining targeted capture next-generation sequencing (NGS), multiplex ligation-dependent probe amplification, and long-range PCR followed by NGS to simultaneously detect point mutations and copy number changes of PMS2. Exonic deletions (E2 to E9, E5 to E9, E8, E10, E14, and E1 to E15), duplications (E11 to E12), and a nonsense mutation, p.S22*, were identified. Traditional multiplex ligation-dependent probe amplification and Sanger sequencing approaches cannot differentiate the origin of the exonic deletions in the 3' region when PMS2 and PMS2CL share identical sequences as a result of gene conversion. Our approach allows unambiguous identification of mutations in the active gene with a straightforward long-range-PCR/NGS method. Breakpoint analysis of multiple samples revealed that recurrent exon 14 deletions are mediated by homologous Alu sequences. Our comprehensive approach provides a reliable tool for accurate molecular analysis of genes containing multiple copies of highly homologous sequences and should improve PMS2 molecular analysis for patients with Lynch syndrome.
Copyright © 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320870     DOI: 10.1016/j.jmoldx.2015.04.001

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  12 in total

1.  Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog.

Authors:  Daniel S Herman; Christina Smith; Chang Liu; Cecily P Vaughn; Selvi Palaniappan; Colin C Pritchard; Brian H Shirts
Journal:  J Mol Diagn       Date:  2018-05-22       Impact factor: 5.568

2.  Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era.

Authors:  Kathleen B M Claes; Toon Rosseel; Kim De Leeneer
Journal:  Methods Mol Biol       Date:  2021

3.  Resolving misalignment interference for NGS-based clinical diagnostics.

Authors:  Che-Yu Lee; Hai-Yun Yen; Alan W Zhong; Hanlin Gao
Journal:  Hum Genet       Date:  2020-09-11       Impact factor: 4.132

4.  Screening for germline mutations in mismatch repair genes in patients with Lynch syndrome by next generation sequencing.

Authors:  Barbara Luísa Soares; Ayslan Castro Brant; Renan Gomes; Tatiane Pastor; Naye Balzan Schneider; Ândrea Ribeiro-Dos-Santos; Paulo Pimentel de Assumpção; Maria Isabel W Achatz; Patrícia Ashton-Prolla; Miguel Angelo Martins Moreira
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

Review 5.  Cancer predisposition in pediatric neuro-oncology-practical approaches and ethical considerations.

Authors:  Steffen Hirsch; Nicola Dikow; Stefan M Pfister; Kristian W Pajtler
Journal:  Neurooncol Pract       Date:  2021-05-28

Review 6.  Sequencing-based diagnostics for pediatric genetic diseases: progress and potential.

Authors:  Ahmad N Abou Tayoun; Bryan Krock; Nancy B Spinner
Journal:  Expert Rev Mol Diagn       Date:  2016-08-17       Impact factor: 5.225

7.  Next Generation Sequencing: From Research Area to Clinical Practice.

Authors:  Chiara Di Resta; Maurizio Ferrari
Journal:  EJIFCC       Date:  2018-11-07

8.  Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.

Authors:  Genevieve M Gould; Peter V Grauman; Mark R Theilmann; Lindsay Spurka; Irving E Wang; Laura M Melroy; Robert G Chin; Dustin H Hite; Clement S Chu; Jared R Maguire; Gregory J Hogan; Dale Muzzey
Journal:  BMC Med Genet       Date:  2018-09-29       Impact factor: 2.103

9.  Atlas-CNV: a validated approach to call single-exon CNVs in the eMERGESeq gene panel.

Authors:  Theodore Chiang; Xiuping Liu; Tsung-Jung Wu; Jianhong Hu; Fritz J Sedlazeck; Simon White; Daniel Schaid; Mariza de Andrade; Gail P Jarvik; David Crosslin; Ian Stanaway; David S Carrell; John J Connolly; Hakon Hakonarson; Emily E Groopman; Ali G Gharavi; Alexander Fedotov; Weimin Bi; Magalie S Leduc; David R Murdock; Yunyun Jiang; Linyan Meng; Christine M Eng; Shu Wen; Yaping Yang; Donna M Muzny; Eric Boerwinkle; William Salerno; Eric Venner; Richard A Gibbs
Journal:  Genet Med       Date:  2019-03-20       Impact factor: 8.822

10.  Accurate Molecular Diagnosis of Gaucher Disease Using Clinical Exome Sequencing as a First-Tier Test.

Authors:  Stefania Zampieri; Silvia Cattarossi; Eleonora Pavan; Antonio Barbato; Agata Fiumara; Paolo Peruzzo; Maurizio Scarpa; Giovanni Ciana; Andrea Dardis
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.